William Palmer
Rheumatology · Omaha, NENPI 1457374910
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Amgen at 55.5% of the total. Reporting peaked in 2019 at $18,931 and has fallen 92.2% since, to $1,475 in 2021. Among rheumatology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $63.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$13K
- Boehringer Ingelheim$6K
- Pfizer$890
- Bristol Myers Squibb$511
- AbbVie$436
- UCB, Inc.$387
- plus $3K from 20 others
Across 155 payments — averaging $3289.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$372K
- Eli Lilly$73K
- Pfizer$34K
- Novartis$19K
- Amgen$12K
What the payments were for
- Consulting fees$4,63019%
- Speaking & faculty fees$11,30047%
- Travel & lodging$1,8368%
- Food & beverage$6,35426%
- Education$1060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 82 | $13,443 |
| Boehringer Ingelheim | 11 | $5,985 |
| Pfizer | 54 | $890 |
| Bristol Myers Squibb | 25 | $511 |
| AbbVie | 28 | $436 |
| UCB, Inc. | 48 | $387 |
| Genentech USA, Inc. | 14 | $310 |
| Mallinckrodt Hospital Products Inc. | 8 | $286 |
| Pacira Therapeutics, Inc. | 7 | $272 |
| Lilly USA, LLC | 16 | $266 |
| GSK | 18 | $229 |
| Novartis | 14 | $225 |
| Johnson & Johnson | 16 | $225 |
| Regeneron Healthcare Solutions, Inc. | 10 | $179 |
| Mallinckrodt Enterprises LLC | 7 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| E.r. Squibb & Sons, L.L.C. | 6 | $81 |
| Antares Pharma, Inc. | 2 | $43 |
| Merck | 3 | $41 |
| Radius Health, Inc. | 3 | $41 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 2 | $29 |
| AstraZeneca | 1 | $20 |
| Boston Scientific | 1 | $19 |
| United Therapeutics Corporation | 1 | $16 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,226 in reported general payments places this provider in the 90th percentile of 39 rheumatology providers in Nebraska.
Other rheumatology in Omaha
- Abhijeet DanveOmaha$118K
- Jay KenikOmaha$69K
- Lynell KlassenOmaha$68K
- Ted MikulsOmaha$23K
- Amandeep RakhraOmaha$12K
- Carolyn CoyleOmaha$6K
- Joseph NahasOmaha$6K
- James OdellOmaha$4K
- Kathryn WildyOmaha$3K
- Harry KleinOmaha$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.